The Bronx, NY Clinical Trials Report — May 2026
5 New Studies, 42 Closing Soon
Hipa.ai Research - May 1, 2026 - Source: Hipa.ai, ClinicalTrials.gov

For residents of The Bronx considering participation in clinical research, May 2026 brings both immediate opportunities and new avenues to contribute to medical science. With 42 trials nearing their enrollment deadlines within the next 90 days, prompt action is essential for interested individuals.
Among these rapidly closing studies, 7 are still actively seeking healthy volunteers, offering a chance to contribute to medical advancements before their enrollment windows close. This urgency extends to patients managing specific health conditions, with trials focused on various cancers and other conditions also facing impending deadlines.
New Research Explores Community Health and Beyond
This month, The Bronx saw the opening of 5 new clinical trials, a slight decrease from the 9 trials that launched in March 2026. This brings the total number of actively recruiting clinical trials in The Bronx, NY, to 560 across 199 research facilities, highlighting the borough's active research landscape.
A particularly notable new trial this May is a large-scale study focused on community health and nutrition:
- The Physicians Committee for Responsible Medicine is sponsoring NCT07595562, "Acceptability of Soy Milk as a Calcium-Rich Beverage in School Children in New York City Public Schools." This study aims for 2,500 participants and will be conducted in NYC Public Schools. It seeks to understand whether students choose and drink soy milk when offered alongside dairy, if offering soy milk can reduce milk waste, and its potential environmental and nutritional impacts.
Other new trials opened this month are exploring a range of conditions and areas, including metastatic malignant neoplasm, ocular hypertension glaucoma, and ovarian cancer. The new trials are diverse in type, with 2 drug trials, 2 "other" type trials, 1 biological trial, and 1 device trial. Industry sponsors, including NextPoint Therapeutics, Inc. and Xencor, Inc., are driving 2 of these new studies, while academic and other organizations, such as Montefiore Medical Center and The New York Eye Surgery Center, sponsor the remaining 3.
Opportunities for Healthy Volunteers
For individuals without a specific medical condition, there are consistent opportunities to contribute to research. Of the 5 new trials launched this month, 1 is actively seeking healthy volunteers. Across The Bronx, a total of 47 clinical trials are currently recruiting healthy participants, providing numerous avenues for those interested in supporting medical research.
Leading Research Facilities in The Bronx
The Bronx is home to several prominent research institutions that consistently run a high volume of clinical trials. These facilities are key destinations for individuals seeking to participate in medical research:
- Montefiore Medical Center (163 trials)
- Montefiore Medical Center - Moses Campus (76 trials)
- Montefiore Medical Center-Einstein Campus (59 trials)
- Montefiore Medical Center-Weiler Hospital (29 trials)
- Research Site (20 trials)
- Albert Einstein College of Medicine (17 trials)
- Children's Hospital at Montefiore (16 trials)
- James J. Peters VA Medical Center, Bronx, NY (14 trials)
- Jacobi Medical Center (12 trials)
- James J Peters VA Medical Center (11 trials)
- Montefiore Einstein Comprehensive Cancer Center (11 trials)
These institutions offer a broad spectrum of research, from comprehensive medical studies at Montefiore Medical Center and its various campuses, to specialized care at Children's Hospital at Montefiore and cancer research at Montefiore Einstein Comprehensive Cancer Center.
Trials Nearing Their End Dates
As enrollment windows close, individuals interested in specific conditions should act quickly. Conditions with trials closing soon include:
- Ovarian cancer (2 trials)
- Pregnancy (2 trials)
- Breast cancer (2 trials)
- Chronic rhinosinusitis with nasal polyps (1 trial)
- Depressive disorder, major (1 trial)
- Colon cancer (1 trial)
- Cervical carcinoma (1 trial)
- COVID-19 vaccination (1 trial)
- COVID-19 (1 trial)
- Depression (1 trial)
Broadening Your Search: Nearby Options
While The Bronx offers a significant number of clinical trial opportunities, individuals may also find options in nearby communities within New York State. Cities with active trials include New York (57 trials), Rochester (8 trials), Buffalo (5 trials), Brooklyn (4 trials), Staten Island (3 trials), Uniondale (3 trials), Harrison (3 trials), and Albany (3 trials).
Participation in clinical trials is open to a diverse range of individuals. Of the 5 new trials launched this month, 2 include children, 2 are female-only, and 3 include older adults, ensuring that various demographic groups have opportunities to contribute to medical science.
As we move further into spring, The Bronx's active research community will continue to drive medical innovation, offering diverse opportunities for individuals to contribute to the future of healthcare.
Data Highlights
Conditions Closing Soon
- ovarian cancer (2)
- pregnancy (2)
- breast cancer (2)
- chronic rhinosinusitis with nasal polyps (1)
- depressive disorder, major (1)
- colon cancer (1)
- cervical carcinoma (1)
- covid-19 vaccination (1)
Most Common New Trial Conditions
- acceptance (1)
- beverage (1)
- choice (1)
- food acceptance (1)
- food tasting (1)
- food waste (1)
- metastatic malignant neoplasm (1)
- new york (1)
Cities With the Most New Trials
Leading Sponsors
- Montefiore Medical Center (1)
- NextPoint Therapeutics, Inc. (1)
- Physicians Committee for Responsible Medicine (1)
- The New York Eye Surgery Center (1)
- Xencor, Inc. (1)
| Month | New Trials | Closing Soon |
|---|---|---|
| December 2025 | 21 | 2 |
| January 2026 | 1 | 2 |
| February 2026 | 9 | 0 |
| March 2026 | 5 | 0 |
| April 2026 | 8 | 7 |
| May 2026 | 5 | 10 |
New Studies This Month (5)
| NCT ID | Title | Phase | Enrollment | Sponsor | Condition | City |
|---|---|---|---|---|---|---|
| NCT07563829 | NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies | Phase 1 | 81 | NextPoint Therapeutics, Inc. | Metastatic Malignant Neoplasm | The Bronx |
| NCT07589270 | Direct Selective Laser Trabeculoplasty (DSLT) for Patients With Glaucoma or Ocular Hypertension Previously Treated With SLT | NA | 60 | The New York Eye Surgery Center | Ocular Hypertension Glaucoma | The Bronx |
| NCT07593092 | Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors | Phase 1 | 90 | Xencor, Inc. | Ovarian Cancer | The Bronx |
| NCT07595302 | Comparing Pain Improvement for Intravenous Versus Oral Acetaminophen in Acute Pelvic Pain | Phase 4 | 140 | Montefiore Medical Center | Pelvic Pain | The Bronx |
| NCT07595562 | Acceptability of Soy Milk as a Calcium-Rich Beverage in School Children in New York City Public Schools | - | 2,500 | Physicians Committee for Responsible Medicine | Food Acceptance | The Bronx |
Top Research Facilities in The Bronx
These research sites are running the most clinical trials in The Bronx, New York.
More Clinical Trials in New York
Other City Research Reports in New York
Compare the May 2026 clinical trials report for The Bronx with other New York cities.
Ready to participate?
Browse every recruiting paid clinical trial in The Bronx, NY, filter by condition, age, and healthy-volunteer status, and jump directly to each study to apply.
Browse Paid Clinical Trials in The Bronx